Recruiting

Observational Study

Sponsor:

Yale University

Code:

NCT03334292

Conditions

Wilson Disease

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

The purpose of the registry/repository is to provide a mechanism to store data and specimens to support the conduct of future research about Wilson disease (WD). The overall aim is to determine the optimal testing for diagnosis and parameters for monitoring treatment of WD that will aid product utilization and development.

Conditions

Wilson Disease

Study ID

NCT03334292

Start date

Dec 18, 2017

Status verified date

Jun, 2026

Completion date

Nov 15, 2029

Anticipated

Primary completion date

Nov 15, 2029

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Known diagnosis of WD
  • Able and willing to provide informed consent for adults (Parental/guardian permission (informed consent) and if appropriate, child assent for participants <18 (or per local Institutional Review Board (IRB) regulation)

Exclusion Criteria:

  • Diagnosis of WD has been excluded
  • Unwilling to provide informed consent or assent

Study Design

Enrollment

300 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • Create registry for Wilson disease [ Time Frame: 5 Years ]

Central Contacts and Locations

Central contacts

Ricarda Tomlin

(203) 785-2073ricarda.tomlin@yale.edu

Sefa Keserci, PhD

(203) 3766043sefa.keserci@yale.edu

Locations

Yale University

Recruiting

New Haven, Connecticut, United States, 06520

Contacts

Sefa Keserci, MD

(203) 3766043sefa.keserci@yale.edu

Asim Ulcay, MD

asim.ulcay@yale.edu

Principal Investigator:

Michael Schilsky, MD

Advent Health

Recruiting

Orlando, Florida, United States, 32803

Contacts

Ariana Mora

Ariana.Mora@AdventHealth.com

Pamela Hedrick

Pamela.Hedrick@AdventHealth.com

Principal Investigator:

Regino Gonzalez-Peralta, MD

Baylor College of Medicine

Recruiting

Houston, Texas, United States, 77030

Contacts

Reza Amerinia

reza.amerinia@bcm.edu

Principal Investigator:

Sanjiv Harpavat, MD

More Information

Sponsor

Yale University

Last update posted

Jun 22, 2026

Last verified

Jun, 2026

Keywords

  • Wilson Disease
  • Copper

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Yale University on 2026-06-22.